Shopping Cart 0
Cart Subtotal

Chinese Blood Products Market Outlook 2017-2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3100

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase


Blood products are those biologicals derived from plasma or obtained by recombinant technologies. The regular blood biologicals which be applied in clinic at present mainly contain albumin, immunoglobulins and coagulation factors. The five-year forecast for Chinese blood products market shows an impressive Compound Annual Growth Rate (CAGR) of 18.9 percent driven by increased demand, according to a new report published by Gen Consulting Company.

The report covers forecast and analysis for the blood products market on a country wise and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the blood products market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Chinese blood products market.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the Chinese blood products market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

On the basis of product types, the report provides separate comprehensive analytics for Chinese albumin, immunoglobulins and coagulation factors market. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in Chinese blood products market.

Key Product Types

Human Albumin

Intravenous Immuneglobulin/IVIG

Rabies Immunoglobulin (RIG)

Hepatitis B Immunoglobulin (HBIG)

Tetanus Immuneglobulin (TIG)

Coagulation Factor VIII


Prothrombin Complex Concentrates (PCC)

Key Regions

North China

East China

South China

Central China


Key Vendors





CSL Behring


Guangming Group

Hansen Medical

Hualan Bio



Octapharma AG

Shanghai RAAS




Key Questions Answered in this Report

What will the market size be in 2022?

What are the key factors driving the Chinese blood products market?

What are the challenges to market growth?

Who are the key players in the blood products market?

What are the market opportunities and threats faced by the key players?


Table Of Content


Part 1. Exclusive Summary

Part 2. Methodology

2.1 Research Methodology

2.2 Geographic Scope

2.3 Years Considered

Part 3. Introduction

3.1 Product Overview

3.2 Types of Blood Products

3.3 Blood Banking Distribution

Part 4. Competitive Landscape

4.1 Chinese Blood Products Market, by Volume 2012-2017

4.1.1 Overview

4.1.2 Chinese Blood Products Market, by Volume, by Company

4.1.3 Top 3 Companies by Volume Share

4.2 Chinese Blood Products Market, by Revenue 2012-2017

4.2.1 Overview

4.2.2 Chinese Blood Products Market, by Revenue, by Company

4.2.3 Top 3 Companies by Revenue Share

Part 5. Market Dynamics

5.1 Market Drivers

5.2 Challenges

Part 6. Human Albumin

6.1 Chinese Human Albumin Market Size 2012-2017

6.1 Chinese Human Albumin Market by Company

Part 7. Intravenous Immuneglobulin/IVIG

7.1 Chinese Intravenous Immuneglobulin/IVIG Market Size 2012-2017

7.2 Chinese Intravenous Immuneglobulin/IVIG Market by Company

Part 8. Rabies Immunoglobulin (RIG)

8.1 Chinese Rabies Immunoglobulin (RIG) Market Size 2012-2017

8.2 Chinese Rabies Immunoglobulin (RIG) Market by Company

Part 9. Hepatitis B Immunoglobulin (HBIG)

9.1 Chinese Hepatitis B Immunoglobulin (HBIG) Market Size 2012-2017

9.2 Chinese Hepatitis B Immunoglobulin (HBIG) Market by Company

Part 10. Tetanus Immuneglobulin (TIG)

10.1 Chinese Tetanus Immuneglobulin (TIG) Market Size 2012-2017

10.2 Chinese Tetanus Immuneglobulin (TIG) Market by Company

Part 11. Coagulation Factor VIII

11.1 Chinese Coagulation Factor VIII Market Size 2012-2017

11.2 Chinese Coagulation Factor VIII Market by Company

Part 12. Fibrinogen

12.1 Chinese Fibrinogen Market Size 2012-2017

12.2 Chinese Fibrinogen Market by Company

Part 13. Prothrombin Complex Concentrates (PCC)

13.1 Chinese Prothrombin Complex Concentrates (PCC) Market Size 2012-2017

13.2 Chinese Prothrombin Complex Concentrates (PCC) Market by Company

Part 14. Consumption Pattern

14.1 North China

14.2 East China

14.3 South China

14.4 Central China

14.5 Other

Part 15. Blood Products Market Forecast

15.1 Chinese Blood Products Market Size 2017-2022

15.2 Chinese Blood Products Market by Region 2017-2022

15.2.1 North China

15.2.2 East China

15.2.3 South China

15.2.4 Central China

15.2.5 Other

15.3 Chinese Blood Products Market by Type 2017-2022

Part 16. Key Vendors

16.1 Company Profiles

16.2 Market Share

16.3 Financials

Part 17. Appendix

17.1 Abbreviations

17.2 Disclaimer

Licence Rights

Single License

allows one individual to access the purchased report

Site License

allows five individuals to access the purchased report

Enterprise License

allows all employees of an organization to access the purchased report

Section Purchase

To know more information on Purchase by Section, please send a mail to